Truist Securities Maintains Buy on Progyny, Lowers Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh maintains a Buy rating on Progyny (NASDAQ:PGNY) but lowers the price target from $37 to $33.
August 07, 2024 | 1:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities analyst Jailendra Singh maintains a Buy rating on Progyny but lowers the price target from $37 to $33.
The Buy rating suggests continued confidence in Progyny's long-term prospects, but the lowered price target indicates some caution about short-term performance. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100